GLP-1R and Diabetes
US$ 20.48
new glp 1 drugs 2025 Weight-loss such as Ozempic were in the headlines a lot in – and patent protections for these drugs expire in some countries in 2026. In this edition of #PeriodicGraphics in @ GLP-1 Drugs: 2025 Pulse Survey
Description
Food and Drug Administration (FDA) and may carry greater risks than FDA-approved treatments
And bulk compounders, called outsourcing facilities, can't fill orders starting 60 days after a shortage ends
That is one reason people often feel full sooner or have less interest in food
Over the past year, the short and long basket actually have a decent correlation (0.779) so this could prove to be a good collection for L/S based on this single factor
Sarath Chandran MD DVL and Dr
Marso, P
